Table 2.
Epidemiology of pathogen co-infections at COVID-19 admission.
| Mild cases (n=8) |
Severe cases (n=33) |
P | |
|---|---|---|---|
| Single pathogen infection (%) | 8 (100) | 18 (54.5) | |
| Mixed pathogen infection (%) | 0 (0) | 15 (45.5) | |
| Fungal infection (%) | 1 (12.5) | 18 (54.5) | 0.032 |
| Candida albicans (%) | 1 (12.5) | 14 (42.4) | 0.115 |
| Aspergillus fumigatus (%) | 0 (0) | 4 (12.1) | |
| Staphylococcus aureus (%) (G+) | 2 (25) | 2 (6.1) | 0.105 |
| Streptococcus pneumoniae (%) (G+) | 1 (12.5) | 2 (6.1) | 0.530 |
| Enterococcus faecalis (%) (G+) | 0 (0) | 1 (3.0) | |
| Staphylococcus hominis (%) (G+) | 0 (0) | 1 (3.0) | |
| Pseudomonas aeruginosa (G-) | 1 (12.5) | 4 (12.1) | 0.977 |
| Acinetobacter baumannii (G-) | 0 (0) | 14 (42.4) | |
| Klebsiella pneumoniae (G-) | 2 (25) | 5 (15.2) | 0.507 |
| Legionella pneumophila (G-) | 1 (12.5) | 0 (0) | |
| Enterobacter asburiae (G-) | 0 (0) | 1 (3.0) | |
| Stenotrophomonas maltophilia (G-) | 0 (0) | 3 (9.1) | |
| Escherichia coli (G-) | 0 (0) | 1 (3.0) | |
| Enterobacter cloacae (G-) | 0 (0) | 2 (6.1) | |
| Mycoplasma pneumoniae | 0 (0) | 4 (12.1) | |
| CR-PA | 0 (0) | 1 (3.0) | |
| CR-AB | 0 (0) | 6 (18.2) | |
| CRE | 0 (0) | 1 (3.0) | |
| No. Death | 0 (0) | 14 (42.4) |
Results are expressed as mean ± standard deviation (SD) or percentage; P values are from a χ2 analysis. G+, Gram positive; G-, Gram negative; CRPA, carbapenem-resistant Pseudomonas aeruginosa; CRAB, carbapenem-resistant Acinetobacter baumannii; CRE, carbapenem-resistant Enterobacteriaceae.